Business, energy, technology, markets and global industry news from Business News Today

Slate Run Pharmaceuticals

PharmaDeviceNews Slate Run Pharmaceuticals
Representative image: Arna Pharma Inc. and Slate Run Pharmaceuticals’ new U.S. specialty pharma joint venture highlights the growing role of respiratory diagnostics, branded niche medicines and 505(b)(2) product strategies, with Aridol emerging as the first commercial test case for the partnership.
Medical Devices & Diagnostics

Can Aridol give Arna Pharma and Slate Run a sharper entry into U.S. respiratory diagnostics?

Specialty pharma needs sharper U.S. routes to market. Arna Pharma and Slate Run are testing that model with Aridol and 505(b)(2) products.

Read More